IMMAGINA Biotechnology has been operating since 2016 as a research-driven SME business operating in the sector of Genomics, Proteomics, and Enabling Technology.
As “The ribosome company” we develop sophisticated tools to capture ribosomes in an active state and characterize their components. Our unique technologies are first-in-class systems allowing for simultaneous measurement of newly synthesized proteins and the RNA template from which they are produced, and delivering the highest level of correlation between gene expression and the proteome. The present platform includes IP covering our technologies and is dedicated to research-use-only (RUO) products with the potential to accelerate the path toward the discovery of novel therapeutic strategies in cancer, other human diseases, and congenital disorders.
IMMAGINA is expected to fully underpin the immense diagnostic potential of a recently developed product portfolio for better decisions in precision medicine and better health.
Our mission is to empower scientists to discover the mechanisms of translational control involved in many diseases and encrypted into ribosomes, bringing to the market breakthrough solutions to solve scientist and patients needs. We can do that thanks to a hybrid business model that embraces both business and sales expansion and a strong clinical diagnostic development.
We design technologies that enable isolation and analysis of active ribosomes and associated RNA molecules. Our solutions focus on accuracy and simplicity so that researchers can implement their own ribosome profiling and translatome studies regardless of their RNA translation expertise.
Our vision is to forge a path to increased understanding of how the ribosomal machine, translational control and the translatome impact disease pathways, ultimately yielding new products and biomarker targets for disease therapies.
I'm interested in the translation of cutting-edge science from academia to the commercial arena. I have a pharmaceutical background and a PhD in biomolecular science carried out between the University of Trento (IT) and the University of Oxford (UK). I enjoy working in bio-business every day with my team, our advisors, and our investors.
My main hobby is playing with my two kids. I love to hike, ski and fish. During my free time I play football, it’s not just the games I love, but also the socializing that comes with them. That being said, I love time alone as well!
Papers I’m most proud of: Detection of 3′-End RNA Uridylation with a Protein Nanopore and Active ribosome profiling with RiboLace
I received my master's degree in chemistry from the University of Padua in 2004. In 2010, I received my PhD in materials engineering from University of Trento. My research concerns the synthesis and functionalization of nanostructured materials for optical and biological applications. I have published about 60 papers in peer-reviewed journals and am the author of two patents.
I love science and I am intrigued by its plethora of possible applications.
Papers most proud of: Multifunctional Branched Gold–Carbon Nanotube Hybrid for Cell Imaging and Drug Delivery
I hold a master's degree with honors in pharmaceutical biotechnology from University of Naples Federico II. Previously, I worked on the selection and characterization of RNA molecules as therapeutic, diagnostic and delivery tools. I love the daily challenges that I am presented with, making this work very interesting on a constant basis. As a biotechnologist, I believe academic results must be translated into industrial success stories.
Papers most proud of: Phospho-RNA sequencing with CircAID-p-seq
I am a passionate and enthusiastic life science and genomics professional with more than 20 years of experience with cutting edge technology providers such as Affymetrix and NuGEN Technologies. I am a biologist and received my PhD in molecular and microbiology from the University of Düsseldorf. Advances in genomics have strongly contributed to groundbreaking insights in biological and medical sciences, and have accelerated the translation into innovation in health and applied biotechnology. It is an exciting opportunity working with Immagina Biotech on developing new technologies that might result in a much deeper understanding of the complex interplay between gene expression, translation and protein synthesis.
My passion is living with my family and playing with my daughter. I enjoy hiking, running and spending time in nature.
PhD , Product Development , Customer Support and Administration
I received a Master of Science degree in evolutionary biology at the University of Padova and a PhD at the University of Modena-Reggio Emilia. My academic background mainly concerns evolutive biology and environmental sciences. While serving the Laboratory of Translational Architectonics at National Research Council (CNR) in Trento, I was involved in the study of gene expression and protein synthesis related to neurodegenerative diseases. I was then further involved in a series of studies related to the evaluation of eco-genotoxicity impacts. I have published more than 20 articles in relevant scientific journals.
I enjoy spending my free time with my family and my friends, walking and visiting new places!
Papers most proud of: In Vivo Translatome Profiling in Spinal Muscular Atrophy Reveals a Role for SMN Protein in Ribosome Biology - SMN-primed ribosomes modulate the translation of transcripts related to spinal muscular atrophy.
I am a passionate biochemist with a PhD in transcription regulation from the University of Oxford. I have always been interested in RNA biology and I believe in the importance of developing innovative approaches that can drive cutting edge science.
I am an avid reader and nature lover, so my free time is split between books and hiking trails.
I am a Medical Biotechnologist with a great interest in Genetics and Clinical Trials. I have accumulated a lot of knowledge in laboratory processes, Quality Management Systems, molecular biology and NGS sequencing. I studied dog training and I am currently following a Masters in Clinical and Preclinical Research at the University of Parma. I am a nature lover, so my free time is often outdoors on sunny days. I like to take care of my family, my dog and my plants.
I am Data Scientist with MSc degree in Bioengineering from Ege University – Turkey. I always be involved with technology and after I found my ultimate passion in coding I decided to be a Data Scientist. My interests includes Machine Learning and Deep Learning applications in sequencing data. I have huge enthusiasm for music and I am total gamer. 01000001 01101110 01100100 00100000 01001001 00100000 01101100 01101111 01110110 01100101 00100000 01100011 01101111 01100100 01101001 01101110 01100111 00100001
I completed my PhD at the University of Trento in 2022 where I developed a new class of non-coding RNA called SINEUP that are able specifically to enhance protein translation by targeting a mRNA of interest. Moreover, I investigated the mechanism of action of a chromatin modifier that is mutated in genetic causes of neurodevelopmental disorders. I am interest in the complexity of the nervous system and how changes in gene expression have consequence in the brain during development. In my spare time I enjoy hiking, snowboarding and traveling to explore different cultures. Papers most proud of: Design and Delivery of SINEUP: A New Modular Tool to Increase Protein Translation
Starting with ideas, I’ve contributed to creating the IMMAGINA vision and mission. First as the only shareholder and employee in IMMAGINA, then with a company team and an alliance of international investors. My work has led to the submission of 6 patents, the development of three technologies, scientific publications and six products from bench to market. I enjoy working in bio-business every day with my team, our advisors, and our investors
Mr. Cogoli has over two decades of experience serving in finance and business administration for multiple companies. He is also a lean management expert and he currently supports many medium and large companies in their growth, organization or reorganization of internal processes. He has applied his lean management expertise in many projects aimed at improving the overall quality and efficacy of internal processes and enhancing companies and their business capabilities. Among his most relevant experience as manager are his appointment as Finance Manager for SEA Group and Administrative Director for Zobele Group. Mr. Cogoli is a Founding Partner at Leanevolution. He holds a Master of Science in Economics from Trento University.
Mr. Kofler serves as an advisor on the IMMAGINA strategic plan. He is the CEO of TBA (Tyrolian Business Angel), identifying and funding relevant high-technology start-ups business in the areas of biotechnology and life sciences. Mr. Kofler is also reporting to I.E.C.T. Hermann Hauser - Tirol, a private institution based in Innsbruck, Austria dedicated to helping entrepreneurs achieve permanent economic success. Mr. Koflers background is in management of innovation projects for medical application and especially within national and European public funding frameworks
Researcher at Institute of Biophysics, CNR Unit, Trento
Gabriella Viero holds a Master of Biology and a PhD in Biotechnology applied to Biomedical Sciences. She is interested in RNA biology, translation and motor neuron diseases. Her laboratory studies polyribosomes by nano-imaging and ribosome profiling. The lab is an interdisciplinary research team with experts in mathematics, information technology, neuropathology and cell biology. Dr. Viero's team has developed methods for studying polysomes in difficult samples and their characterization by POLSeq and RIBO-Seq. Recent combined output includes papers in top journals (J. Cell. Biol., NAR, Bioinformatics, Nat. Comm., Cell Reports, Mol. Cell).
Personal web page: https://www.facebook.com/LabTranslationalArchitectomics/